Lung cancer causes the most cancer-related deaths worldwide. In recent years, molecular
and immunohistochemical techniques have rapidly developed, further inaugurating an era …

Oncogenes that occur in≤ 5% of non-small-cell lung cancers have been defined as 'rare';
nonetheless, this frequency can correspond to a substantial number of patients diagnosed …

Lung cancer is the leading cause of malignancy-related death in the United States and the
second most common cancer diagnosis worldwide. In the last two decades, lung cancer …

Lung cancer remains a formidable global health challenge that necessitates inventive
strategies to improve its therapeutic outcomes. The conventional treatments, including …

Lung cancer encompasses a diverse spectrum of histologic subtypes. Until recently, the
majority of therapeutic advances were limited to the minority of patients with …

Lung cancer is the leading cause of cancer-related deaths in the United States and the 5-
year overall survival outlook for a patient has not improved in several decades. Recently …

Although lung cancer remains the leading cancer killer in the United States, recently a
number of developments indicate future clinical benefit. These include evidence that …

Lung cancer is the leading cause of cancer death worldwide, causing 1.4 million deaths
annually [1]. Patients with advanced stage nonsmall cell lung cancer (NSCLC) are usually …

Lung cancer is the leading cause of cancer deaths associated with poor prognosis. Patients
with advanced lung cancer had been “uniformly” treated with platinum-based cytotoxic …

Over the last decade, systemic cancer therapies have evolved to exploit the growing
knowledge of molecular aberrations involved in the development and progression of lung …